Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The cadherin antibody (Proteintech, 20874-1-AP, 1:50000) was chosen as the internal control for LAT1 on the cell membrane
While most supplements seem harmless, some can interact with these medications in ways that lead to unwelcome side effects think gastrointestinal (GI) issues, nutrient deficiencies or even dangerously low blood sugar
Progressing K-554, a potential first-in-class non-incretin peptide for metabolic disease, to Phase 1 studies, with early data expected H2 2026 Kallyope, a late-stage biotechnology company focused on developing innovative migraine and metabolic disease therapies for health challenges faced by hundreds of millions of people globally, announced the Companys strategic priorities for 2026
Genetic and non-genetic mechanisms underlying cancer evolution, Cancers (Basel)
US$ 29.74
US$ 25.85
US$ 28.83
US$ 24.00
US$ 21.51
US$ 26.26
US$ 22.76
US$ 24.28
